Table of Content


1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Lung Cancer Diagnostics Market


6. Market Share – Global Lung Cancer Diagnostics Analysis

6.1 By Diagnosis Test Type
6.2 By Cancer Type
6.3 By EndUsers
6.4 By Country


7. Diagnosis Test Type – Global Lung Cancer Diagnostics Market

7.1 Imaging Test
7.2 Biopsy
7.3 Sputum Cytology
7.4 Molecular Test
7.5 Others


8. Cancer Type – Global Lung Cancer Diagnostics Market

8.1 Non- Small Cell Lung Cancer
8.2 Small Cell Lung Cancer


9. End-User – Global Lung Cancer Diagnostics Market

9.1 Hospital Associated Labs
9.2 Independent Diagnostic Laboratories
9.3 Diagnostic Imaging Centers
9.4 Cancer Research Institutes
9.5 Others


10. Country – Global Lung Cancer Diagnostics Market

10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey

10.3 Asia Pacific

10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand

10.4 Latin America

10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina

10.5 Middle East & Africa

10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 South Africa


11. Porter’s Five Analysis – Global Lung Cancer Diagnostics Market

11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis – Global Lung Cancer Diagnostics Market

12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat


13. Company Analysis – Global Lung Cancer Diagnostics Market

13.1 llumina

13.1.1 Overviews
13.1.2 Recent Development
13.1.3 Revenues

13.2 Abbott Laboratories

13.2.1 Overviews
13.2.2 Recent Development
13.2.3 Revenues

13.3 Thermo Fisher Scientific, Inc

13.3.1 Overviews
13.3.2 Recent Development
13.3.3 Revenues

13.4 QIAGEN N.V.

13.4.1 Overviews
13.4.2 Recent Development
13.4.3 Revenues

13.5 Roche Holding AG.

13.5.1 Overviews
13.5.2 Recent Development
13.5.3 Revenues

13.6 Sanofi S.A.

13.6.1 Overview
13.6.2 Recent Development
13.6.3 Financial Insights

13.7 Agilent Technologies

13.7.1 Overview
13.7.2 Recent Development
13.7.3 Financial Insights

13.8 bioM?rieux

13.8.1 Overview
13.8.2 Recent Development
13.8.3 Financial Insights



List of Figures


Figure-01: Global – Lung Cancer Diagnostics Market (Billion US$), 2019 – 2023
Figure-02: Global – Forecast for Lung Cancer Diagnostics Market (Billion US$), 2024 – 2030
Figure-03: Diagnosis Test Type – Imaging Test Market (Million US$), 2019 – 2023
Figure-04: Diagnosis Test Type – Forecast for Imaging Test Market (Million US$), 2024 – 2030
Figure-05: Diagnosis Test Type – Biopsy Market (Million US$), 2019 – 2023
Figure-06: Diagnosis Test Type – Forecast for Biopsy Market (Million US$), 2024 – 2030
Figure-07: Diagnosis Test Type – Sputum Cytology Market (Million US$), 2019 – 2023
Figure-08: Diagnosis Test Type – Forecast for Sputum Cytology Market (Million US$), 2024 – 2030
Figure-09: Diagnosis Test Type – Molecular Test Market (Million US$), 2019 – 2023
Figure-10: Diagnosis Test Type – Forecast for Molecular Test Market (Million US$), 2024 – 2030
Figure-11: Diagnosis Test Type – Others Market (Million US$), 2019 – 2023
Figure-12: Diagnosis Test Type – Forecast for Others Market (Million US$), 2024 – 2030
Figure-13: Cancer Type – Non- Small Cell Lung Cancer Market (Million US$), 2019 – 2023
Figure-14: Cancer Type – Forecast for Non- Small Cell Lung Cancer Market (Million US$), 2024 – 2030
Figure-15: Cancer Type – Small Cell Lung Cancer Market (Million US$), 2019 – 2023
Figure-16: Cancer Type – Forecast for Small Cell Lung Cancer Market (Million US$), 2024 – 2030
Figure-17: End-User – Hospital Associated Labs Market (Million US$), 2019 – 2023
Figure-18: End-User – Forecast for Hospital Associated Labs Market (Million US$), 2024 – 2030
Figure-19: End-User – Independent Diagnostic Laboratories Market (Million US$), 2019 – 2023
Figure-20: End-User – Forecast for Independent Diagnostic Laboratories Market (Million US$), 2024 – 2030
Figure-21: End-User – Diagnostic Imaging Centers Market (Million US$), 2019 – 2023
Figure-22: End-User – Forecast for Diagnostic Imaging Centers Market (Million US$), 2024 – 2030
Figure-23: End-User – Cancer Research Institutes Market (Million US$), 2019 – 2023
Figure-24: End-User – Forecast for Cancer Research Institutes Market (Million US$), 2024 – 2030
Figure-25: End-User – Others Market (Million US$), 2019 – 2023
Figure-26: End-User – Forecast for Others Market (Million US$), 2024 – 2030
Figure-27: United States – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-28: United States – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-29: Canada – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-30: Canada – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-31: France – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-32: France – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-33: Germany – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-34: Germany – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-35: Italy – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-36: Italy – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-37: Spain – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-38: Spain – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-39: United Kingdom – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-40: United Kingdom – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-41: Belgium – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-42: Belgium – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-43: Netherlands – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-44: Netherlands – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-45: Turkey – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-46: Turkey – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-47: China – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-48: China – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-49: Japan – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-50: Japan – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-51: India – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-52: India – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-53: South Korea – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-54: South Korea – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-55: Thailand – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-56: Thailand – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-57: Malaysia – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-58: Malaysia – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-59: Indonesia – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-60: Indonesia – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-61: Australia – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-62: Australia – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-63: New Zealand – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-64: New Zealand – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-65: Brazil – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-66: Brazil – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-67: Mexico – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-68: Mexico – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-69: Argentina – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-70: Argentina – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-71: Saudi Arabia – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-72: Saudi Arabia – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-73: UAE – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-74: UAE – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-75: South Africa – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-76: South Africa – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-77: llumina – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-78: llumina – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-79: Abbott Laboratories – Global Revenue (Million US$), 2019 – 2023
Figure-80: Abbott Laboratories – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-81: Thermo Fisher Scientific, Inc – Global Revenue (Million US$), 2019 – 2023
Figure-82: Thermo Fisher Scientific, Inc – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-83: QIAGEN N.V. – Global Revenue (Million US$), 2019 – 2023
Figure-84: QIAGEN N.V. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-85: Roche Holding AG. – Global Revenue (Million US$), 2019 – 2023
Figure-86: Roche Holding AG. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-87: Sanofi S.A. – Global Revenue (Million US$), 2019 – 2023
Figure-88: Sanofi S.A. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-89: Agilent Technologies – Global Revenue (Million US$), 2019 – 2023
Figure-90: Agilent Technologies – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-91: bioM?rieux – Global Revenue (Million US$), 2019 – 2023
Figure-92: bioM?rieux – Forecast for Global Revenue (Million US$), 2024 – 2030

List of Tables


Table-01: Global – Lung Cancer Diagnostics Market Share by Diagnosis Test Type (Percent), 2019 – 2023
Table-02: Global – Forecast for Lung Cancer Diagnostics Market Share by Diagnosis Test Type (Percent), 2024 – 2030
Table-03: Global –Lung Cancer Diagnostics Market Share by Cancer Type (Percent), 2019 – 2023
Table-04: Global – Forecast for Lung Cancer Diagnostics Market Share by Cancer Type (Percent), 2024 – 2030
Table-05: Global – Lung Cancer Diagnostics Market Share by End-User (Percent), 2019 – 2023
Table-06: Global – Forecast for Lung Cancer Diagnostics Market Share by End-User (Percent), 2024 – 2030
Table-07: Global – Lung Cancer Diagnostics Market Share by Region (Percent), 2019 – 2023
Table-08: Global – Forecast for Lung Cancer Diagnostics Market Share by Region (Percent), 2024 – 2030